『Broad-spectrum anti-inflammatory enzyme ‘Tokinase Tablet’ launched』

 

 

KyungDong Pharm Co., Ltd. releases ‘Tokinase Tablet’, a broad-spectrum anti-inflammatory enzyme drug, on December 1, 2013.

 

‘Tokinase Tablet’ is a product containing 10,000 I.U. of streptokinase and 2,500 I.U. of streptodornase per tablet. It is an anti-inflammatory enzyme medication widely used for inflammation-related diseases due to its rapid anti-inflammatory analgesic effect and thickening and phlegm discharging effect.

 

‘Dokinase tablets’, a combination of streptokinase, a fibrinolytic enzyme, and streptodornase, a DNA-degrading enzyme, removes the biofilm of infectious bacteria, increases the effectiveness of antibiotics, and acts to relieve inflammation.

 

‘Tokinase Tablet’ is a safe enzyme preparation with few side effects, and is expected to be helpful in treating various inflammatory diseases in most departments.

 

 

 

♤ Product Information ♤

 

◇Product name: Tokinase tablets

 

◇Ingredient content: Streptokinase 10,000I.U. Streptodornase 2,500I.U.

 

◇Effectiveness: 1. Relief of inflammatory edema of the following diseases and symptoms: After surgery and trauma, sinusitis, thrombophlebitis

2. Difficulty expelling sputum due to respiratory disease

 

◇Dosage: Adults: 1 to 2 tablets at a time, orally 4 times a day.

 

◇Insurance price: 70 won / tablet

 

◇Insurance code: 648103330

 

◇Packaging unit: 500 tablets

 

※ Please refer to the product manual for other details such as precautions for use.